Automotive production and inventory, and ultimately sales, all took a massive hit and still have not been the same since, reports GlobalData.

The Fed’s top banking regulator Michael Barr will step down in February after the new Trump administration takes over.

One driver is the introduction of drugs targeting unmet needs. The heart failure (HF) sector across the seven major markets ...

The company says the early trial of its androgenic alopecia therapy saw patients benefit from six times more hair growth than ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.